Moyamoya Disease Explored Through RNF213
Genetics, Molecular Pathology, and Clinical Sciences
Published on 7. August 2018
Book
Paperback/Softback
VIII, 185 pages
978-981-10-9689-1 (ISBN)
Description
This book presents the latest findings on biological, epidemiological, and clinical investigations of
RNF213
, which is thought to be involved in many biological processes and plays a key role in cerebro- and cardiovascular disease . By discussing the epidemiology and genetic epidemiology of the disease with a particular focus on the molecular function of
RNF213
, research using animal models, diagnosis, therapy and clinical management around the world, this work makes a valuable contribution to the study of the disease.
Moyamoya Disease Explored Through RNF213
is an indispensable resource for both beginning and experienced researchers, pediatricians, neurologists, and neurosurgeons who are seeking comprehensive information on adult and childhood stroke.
More details
Series
Edition
Softcover reprint of the original 1st ed. 2017
Language
English
Place of publication
Singapore
Singapore
Target group
Professional and scholarly
Illustrations
14 s/w Abbildungen, 22 farbige Abbildungen
VIII, 185 p. 36 illus., 22 illus. in color.
Dimensions
Height: 235 mm
Width: 155 mm
Thickness: 11 mm
Weight
342 gr
ISBN-13
978-981-10-9689-1 (9789811096891)
DOI
10.1007/978-981-10-2711-6
Schweitzer Classification
Other editions
Additional editions
Akio Koizumi | Kazuhiro Nagata | Kiyohiro Houkin
Moyamoya Disease Explored Through RNF213
Genetics, Molecular Pathology, and Clinical Sciences
Book
03/2017
Springer
€106.99
Shipment within 15-20 days
Persons
Akio Koizumi, Department of Health and Environmental Sciences, Graduate School of Medicine, Kyoto UniversityKazuhiro Nagata, Laboratory of Molecular and Cellular biology, Faculty of Life Sciences, Kyoto Sangyo UniversityKiyohiro Houkin, Department of Neurosurgery, Graduate School of Medicine, Hokkaido UniversityTeiji Tominaga, Department of Neurosurgery, Tohoku University School of Medicine Susumu Miyamoto, Department of Neurosurgery, Graduate School of Medicine, Kyoto UniversityShigeo Kure, Department of Pediatrics, Tohoku University School of MedicineElizabeth Tournier-Lasserve, CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Lariboisière
Content
Part I: Prologue.-
1. A prologue to moyamoya disease and RNF213.-
2. Concept of moyamoya Disease.-
Part II: Genetic Epidemiology.-
3. Molecular Epidemiology in East Asian Countries and in the World.-
Part III: Biochemistry, Function and Molecular Pathology.-
4. Molecular Biology of Mysterin/RNF213.-
5. Physiological Role of Mysterin/RNF213 in Zebrafish.-
6. Pathological Investigation on RNF213 : Animal Models Knockout and Transgenic Mice in Diabetes and Signal Transduction.-
7. Pathological Investigation on RNF213 : Animal Models of Rnf213 -knockout and Knock-in Mice.-
8. RNF213 and Circulating Factors in Patients with Moyamoya Disease .-
9. Genetics of Moyamoya beyond RNF213 . Monogenic Moyamoya Syndromes.-
Part IV: Clinical Management
10. Natural History and Long-term Clinical Outcome after Conservative and Surgical Management.-
11. Significance of RNF213 in Clinical Management in Japan.-
12. Significance of RNF213 in Clinical Management in China.-
13. The Different Forms of Moyamoya Disease and Their Clinical Management.-
14. Vascular Diseases Attributable to RNF213 Other than Moyamoya Disease.-
Part V: Epilogue.-
Future Clinical Perspectives on RNF213 in Moyamoya Disease.
1. A prologue to moyamoya disease and RNF213.-
2. Concept of moyamoya Disease.-
Part II: Genetic Epidemiology.-
3. Molecular Epidemiology in East Asian Countries and in the World.-
Part III: Biochemistry, Function and Molecular Pathology.-
4. Molecular Biology of Mysterin/RNF213.-
5. Physiological Role of Mysterin/RNF213 in Zebrafish.-
6. Pathological Investigation on RNF213 : Animal Models Knockout and Transgenic Mice in Diabetes and Signal Transduction.-
7. Pathological Investigation on RNF213 : Animal Models of Rnf213 -knockout and Knock-in Mice.-
8. RNF213 and Circulating Factors in Patients with Moyamoya Disease .-
9. Genetics of Moyamoya beyond RNF213 . Monogenic Moyamoya Syndromes.-
Part IV: Clinical Management
10. Natural History and Long-term Clinical Outcome after Conservative and Surgical Management.-
11. Significance of RNF213 in Clinical Management in Japan.-
12. Significance of RNF213 in Clinical Management in China.-
13. The Different Forms of Moyamoya Disease and Their Clinical Management.-
14. Vascular Diseases Attributable to RNF213 Other than Moyamoya Disease.-
Part V: Epilogue.-
Future Clinical Perspectives on RNF213 in Moyamoya Disease.